25 XP   0   0   10

Myungmoon Phar
Buy, Hold or Sell?

Let's analyse Myungmoon Phar together

PenkeI guess you are interested in Myungmoon Phar. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Myungmoon Phar. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Myungmoon Phar

I send you an email if I find something interesting about Myungmoon Phar.

Quick analysis of Myungmoon Phar (30 sec.)










What can you expect buying and holding a share of Myungmoon Phar? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
45.0%

What is your share worth?

Current worth
₩2,646.84
Expected worth in 1 year
₩2,475.60
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
₩-171.24
Return On Investment
-8.3%

For what price can you sell your share?

Current Price per Share
₩2,075.00
Expected price per share
₩1,962 - ₩2,340
How sure are you?
50%

1. Valuation of Myungmoon Phar (5 min.)




Live pricePrice per Share (EOD)

₩2,075.00

Intrinsic Value Per Share

₩12,941.43 - ₩15,611.48

Total Value Per Share

₩15,588.27 - ₩18,258.32

2. Growth of Myungmoon Phar (5 min.)




Is Myungmoon Phar growing?

Current yearPrevious yearGrowGrow %
How rich?$62.1m$63m$2.3m3.6%

How much money is Myungmoon Phar making?

Current yearPrevious yearGrowGrow %
Making money-$791.8k$1.3m-$2.1m-273.9%
Net Profit Margin-2.6%5.0%--

How much money comes from the company's main activities?

3. Financial Health of Myungmoon Phar (5 min.)




What can you expect buying and holding a share of Myungmoon Phar? (5 min.)

Welcome investor! Myungmoon Phar's management wants to use your money to grow the business. In return you get a share of Myungmoon Phar.

What can you expect buying and holding a share of Myungmoon Phar?

First you should know what it really means to hold a share of Myungmoon Phar. And how you can make/lose money.

Speculation

The Price per Share of Myungmoon Phar is ₩2,075. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Myungmoon Phar.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Myungmoon Phar, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,646.84. Based on the TTM, the Book Value Change Per Share is ₩-42.81 per quarter. Based on the YOY, the Book Value Change Per Share is ₩69.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Myungmoon Phar.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.080.0%-0.020.0%0.020.0%-0.060.0%-0.020.0%
Usd Book Value Change Per Share-0.110.0%-0.030.0%0.050.0%0.000.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.0%
Usd Total Gains Per Share-0.110.0%-0.030.0%0.050.0%0.000.0%0.010.0%
Usd Price Per Share1.60-1.66-2.21-3.08-3.27-
Price to Earnings Ratio-4.75--34.91-79.09--5.86-27.58-
Price-to-Total Gains Ratio-14.90--95.83-259.45--69.45--41.29-
Price to Book Ratio0.86-0.85-1.19-1.64-1.79-
Price-to-Total Gains Ratio-14.90--95.83-259.45--69.45--41.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.4525
Number of shares688
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.00
Usd Total Gains Per Share-0.030.00
Gains per Quarter (688 shares)-20.62-3.10
Gains per Year (688 shares)-82.47-12.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-82-920-12-22
20-165-1740-25-34
30-247-2560-37-46
40-330-3380-50-58
50-412-4200-62-70
60-495-5020-75-82
70-577-5840-87-94
80-660-6660-99-106
90-742-7480-112-118
100-825-8300-124-130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%7.05.00.058.3%7.013.00.035.0%22.014.04.055.0%24.014.06.054.5%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%9.011.00.045.0%19.021.00.047.5%21.023.00.047.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%18.00.022.045.0%18.00.026.040.9%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%9.011.00.045.0%20.020.00.050.0%22.022.00.050.0%

Fundamentals of Myungmoon Phar

About Myungmoon Phar

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, antidiarrheal agents, digestive system products, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-15 01:10:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Myungmoon Phar.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Myungmoon Phar earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Myungmoon Phar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -9.4% means that ₩-0.09 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Myungmoon Phar:

  • The MRQ is -9.4%. The company is making a loss. -1
  • The TTM is -2.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-2.6%-6.8%
TTM-2.6%YOY5.0%-7.6%
TTM-2.6%5Y-7.4%+4.8%
5Y-7.4%10Y-2.4%-5.0%
1.1.2. Return on Assets

Shows how efficient Myungmoon Phar is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Myungmoon Phar to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.7% Return on Assets means that Myungmoon Phar generated ₩-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Myungmoon Phar:

  • The MRQ is -1.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.7%TTM-0.5%-1.2%
TTM-0.5%YOY0.9%-1.3%
TTM-0.5%5Y-1.0%+0.5%
5Y-1.0%10Y-0.3%-0.7%
1.1.3. Return on Equity

Shows how efficient Myungmoon Phar is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Myungmoon Phar to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.8% Return on Equity means Myungmoon Phar generated ₩-0.05 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Myungmoon Phar:

  • The MRQ is -4.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.8%TTM-1.3%-3.5%
TTM-1.3%YOY2.3%-3.6%
TTM-1.3%5Y-3.1%+1.7%
5Y-3.1%10Y-1.0%-2.1%

1.2. Operating Efficiency of Myungmoon Phar.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Myungmoon Phar is operating .

  • Measures how much profit Myungmoon Phar makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Myungmoon Phar to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Myungmoon Phar:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.8%-0.8%
TTM0.8%YOY2.7%-1.9%
TTM0.8%5Y-5.9%+6.7%
5Y-5.9%10Y-2.0%-3.9%
1.2.2. Operating Ratio

Measures how efficient Myungmoon Phar is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.51 means that the operating costs are ₩1.51 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Myungmoon Phar:

  • The MRQ is 1.513. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.165. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.513TTM1.165+0.348
TTM1.165YOY1.325-0.160
TTM1.1655Y1.447-0.282
5Y1.44710Y1.172+0.275

1.3. Liquidity of Myungmoon Phar.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Myungmoon Phar is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.70 means the company has ₩0.70 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Myungmoon Phar:

  • The MRQ is 0.700. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.688. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.700TTM0.688+0.012
TTM0.688YOY0.624+0.064
TTM0.6885Y0.709-0.021
5Y0.70910Y0.568+0.141
1.3.2. Quick Ratio

Measures if Myungmoon Phar is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Myungmoon Phar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.32 means the company can pay off ₩0.32 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Myungmoon Phar:

  • The MRQ is 0.320. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.328. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.320TTM0.328-0.008
TTM0.328YOY0.315+0.013
TTM0.3285Y0.395-0.067
5Y0.39510Y0.519-0.124

1.4. Solvency of Myungmoon Phar.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Myungmoon Phar assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Myungmoon Phar to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.62 means that Myungmoon Phar assets are financed with 62.5% credit (debt) and the remaining percentage (100% - 62.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Myungmoon Phar:

  • The MRQ is 0.625. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.603. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.625TTM0.603+0.022
TTM0.603YOY0.600+0.003
TTM0.6035Y0.624-0.021
5Y0.62410Y0.614+0.010
1.4.2. Debt to Equity Ratio

Measures if Myungmoon Phar is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Myungmoon Phar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 177.1% means that company has ₩1.77 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Myungmoon Phar:

  • The MRQ is 1.771. The company is just able to pay all its debts with equity.
  • The TTM is 1.617. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.771TTM1.617+0.154
TTM1.617YOY1.600+0.017
TTM1.6175Y1.773-0.156
5Y1.77310Y1.700+0.072

2. Market Valuation of Myungmoon Phar

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Myungmoon Phar generates.

  • Above 15 is considered overpriced but always compare Myungmoon Phar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.75 means the investor is paying ₩-4.75 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Myungmoon Phar:

  • The EOD is -4.315. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.751. Based on the earnings, the company is expensive. -2
  • The TTM is -34.912. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.315MRQ-4.751+0.437
MRQ-4.751TTM-34.912+30.161
TTM-34.912YOY79.090-114.002
TTM-34.9125Y-5.865-29.047
5Y-5.86510Y27.579-33.444
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Myungmoon Phar:

  • The EOD is -15.879. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.486. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -22.643. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.879MRQ-17.486+1.607
MRQ-17.486TTM-22.643+5.156
TTM-22.643YOY-4.702-17.941
TTM-22.6435Y-8.972-13.671
5Y-8.97210Y-3.683-5.289
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Myungmoon Phar is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.86 means the investor is paying ₩0.86 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Myungmoon Phar:

  • The EOD is 0.784. Based on the equity, the company is cheap. +2
  • The MRQ is 0.863. Based on the equity, the company is cheap. +2
  • The TTM is 0.855. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.784MRQ0.863-0.079
MRQ0.863TTM0.855+0.008
TTM0.855YOY1.191-0.336
TTM0.8555Y1.638-0.783
5Y1.63810Y1.789-0.152
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Myungmoon Phar compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---153.317-42.811-72%69.469-321%-6.447-96%11.590-1423%
Book Value Per Share--2646.8382775.161-5%2664.399-1%2695.067-2%2602.056+2%
Current Ratio--0.7000.688+2%0.624+12%0.709-1%0.568+23%
Debt To Asset Ratio--0.6250.603+4%0.600+4%0.624+0%0.614+2%
Debt To Equity Ratio--1.7711.617+10%1.600+11%1.7730%1.700+4%
Dividend Per Share----0%-0%-0%7.454-100%
Eps---120.233-33.762-72%28.234-526%-82.746-31%-28.266-76%
Free Cash Flow Per Share---32.668-60.513+85%26.082-225%-60.052+84%-49.217+51%
Free Cash Flow To Equity Per Share---32.6683.986-920%39.113-184%8.582-481%16.758-295%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max--15611.485--------
Intrinsic Value_10Y_min--12941.432--------
Intrinsic Value_1Y_max--191.501--------
Intrinsic Value_1Y_min--187.294--------
Intrinsic Value_3Y_max--1621.677--------
Intrinsic Value_3Y_min--1527.064--------
Intrinsic Value_5Y_max--4313.281--------
Intrinsic Value_5Y_min--3913.423--------
Market Cap69568940000.000-10%76621264370.00079896540275.000-4%106741781925.000-28%148089785109.624-48%157058236737.364-51%
Net Profit Margin---0.094-0.026-72%0.050-288%-0.074-21%-0.024-74%
Operating Margin---0.008-100%0.027-100%-0.0590%-0.0200%
Operating Ratio--1.5131.165+30%1.325+14%1.447+5%1.172+29%
Pb Ratio0.784-10%0.8630.855+1%1.191-27%1.638-47%1.789-52%
Pe Ratio-4.315+9%-4.751-34.912+635%79.090-106%-5.865+23%27.579-117%
Price Per Share2075.000-10%2285.0002372.500-4%3157.500-28%4395.000-48%4673.500-51%
Price To Free Cash Flow Ratio-15.879+9%-17.486-22.643+29%-4.702-73%-8.972-49%-3.683-79%
Price To Total Gains Ratio-13.534+9%-14.904-95.832+543%259.451-106%-69.445+366%-41.293+177%
Quick Ratio--0.3200.328-3%0.315+2%0.395-19%0.519-38%
Return On Assets---0.017-0.005-72%0.009-297%-0.010-41%-0.003-83%
Return On Equity---0.048-0.013-72%0.023-313%-0.031-36%-0.010-79%
Total Gains Per Share---153.317-42.811-72%69.469-321%-6.447-96%19.044-905%
Usd Book Value--62128172.70865410832.750-5%63050474.853-1%63571091.951-2%61227972.243+1%
Usd Book Value Change Per Share---0.107-0.030-72%0.049-321%-0.005-96%0.008-1423%
Usd Book Value Per Share--1.8531.943-5%1.865-1%1.887-2%1.821+2%
Usd Dividend Per Share----0%-0%-0%0.005-100%
Usd Eps---0.084-0.024-72%0.020-526%-0.058-31%-0.020-76%
Usd Free Cash Flow---766813.453-1429964.975+86%617195.031-224%-1412818.553+84%-1012420.922+32%
Usd Free Cash Flow Per Share---0.023-0.042+85%0.018-225%-0.042+84%-0.034+51%
Usd Free Cash Flow To Equity Per Share---0.0230.003-920%0.027-184%0.006-481%0.012-295%
Usd Market Cap48698258.000-10%53634885.05955927578.193-4%74719247.348-28%103662849.577-48%109940765.716-51%
Usd Price Per Share1.453-10%1.6001.661-4%2.210-28%3.077-48%3.271-51%
Usd Profit---2822176.189-791846.578-72%1376897.709-305%-1804448.905-36%-594623.971-79%
Usd Revenue--29993284.41929674290.277+1%26623614.549+13%26028147.171+15%24569985.718+22%
Usd Total Gains Per Share---0.107-0.030-72%0.049-321%-0.005-96%0.013-905%
 EOD+3 -5MRQTTM+7 -26YOY+7 -265Y+9 -2310Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Myungmoon Phar based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.315
Price to Book Ratio (EOD)Between0-10.784
Net Profit Margin (MRQ)Greater than0-0.094
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.320
Current Ratio (MRQ)Greater than10.700
Debt to Asset Ratio (MRQ)Less than10.625
Debt to Equity Ratio (MRQ)Less than11.771
Return on Equity (MRQ)Greater than0.15-0.048
Return on Assets (MRQ)Greater than0.05-0.017
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Myungmoon Phar based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.500
Ma 20Greater thanMa 502,176.000
Ma 50Greater thanMa 1002,157.700
Ma 100Greater thanMa 2002,217.450
OpenGreater thanClose2,075.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets236,548,794
Total Liabilities147,794,261
Total Stockholder Equity83,453,011
 As reported
Total Liabilities 147,794,261
Total Stockholder Equity+ 83,453,011
Total Assets = 236,548,794

Assets

Total Assets236,548,794
Total Current Assets81,436,186
Long-term Assets155,112,608
Total Current Assets
Cash And Cash Equivalents 7,961,794
Short-term Investments 3,702,653
Net Receivables 33,488,719
Inventory 30,280,253
Other Current Assets 0
Total Current Assets  (as reported)81,436,186
Total Current Assets  (calculated)75,433,418
+/- 6,002,768
Long-term Assets
Property Plant Equipment 140,195,918
Intangible Assets 267,486
Long-term Assets Other 335,330
Long-term Assets  (as reported)155,112,608
Long-term Assets  (calculated)140,798,735
+/- 14,313,873

Liabilities & Shareholders' Equity

Total Current Liabilities116,372,828
Long-term Liabilities31,421,433
Total Stockholder Equity83,453,011
Total Current Liabilities
Short Long Term Debt 76,514,811
Accounts payable 16,746,436
Other Current Liabilities 1,572,372
Total Current Liabilities  (as reported)116,372,828
Total Current Liabilities  (calculated)94,833,620
+/- 21,539,208
Long-term Liabilities
Long term Debt 12,584,200
Capital Lease Obligations Min Short Term Debt1,383,187
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)31,421,433
Long-term Liabilities  (calculated)13,967,387
+/- 17,454,047
Total Stockholder Equity
Retained Earnings 6,031,008
Total Stockholder Equity (as reported)83,453,011
Total Stockholder Equity (calculated)6,031,008
+/- 77,422,003
Other
Capital Stock16,976,727
Common Stock Shares Outstanding 33,532
Net Debt 81,137,218
Net Invested Capital 172,552,022
Net Working Capital -34,936,642
Property Plant and Equipment Gross 176,776,917



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
193,163,468
196,283,381
192,436,712
192,410,404
191,925,011
190,241,940
185,295,893
190,660,551
194,205,321
191,334,104
196,940,826
199,417,323
203,195,863
201,857,288
216,357,532
221,075,417
216,214,203
221,656,403
222,160,313
235,076,921
241,696,117
237,585,205
242,349,079
243,065,788
258,799,320
257,192,537
259,093,657
264,441,725
258,576,554
275,520,564
264,641,704
243,025,043
240,300,697
234,622,364
231,575,516
222,676,164
223,351,228
222,094,394
223,714,441
230,449,823
232,228,080
235,804,275
237,027,751
236,548,794
236,548,794237,027,751235,804,275232,228,080230,449,823223,714,441222,094,394223,351,228222,676,164231,575,516234,622,364240,300,697243,025,043264,641,704275,520,564258,576,554264,441,725259,093,657257,192,537258,799,320243,065,788242,349,079237,585,205241,696,117235,076,921222,160,313221,656,403216,214,203221,075,417216,357,532201,857,288203,195,863199,417,323196,940,826191,334,104194,205,321190,660,551185,295,893190,241,940191,925,011192,410,404192,436,712196,283,381193,163,468
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
111,853,936
105,686,314
110,196,767
104,323,336
106,553,579
110,623,327
106,392,106
114,213,107
106,970,793
120,261,380
115,158,589
110,868,786
100,741,630
97,328,227
113,104,142
101,578,249
80,577,326
78,937,377
74,272,063
70,923,216
67,466,131
67,677,326
67,309,145
68,111,948
70,706,928
75,995,847
78,998,245
81,113,596
81,436,186
81,436,18681,113,59678,998,24575,995,84770,706,92868,111,94867,309,14567,677,32667,466,13170,923,21674,272,06378,937,37780,577,326101,578,249113,104,14297,328,227100,741,630110,868,786115,158,589120,261,380106,970,793114,213,107106,392,106110,623,327106,553,579104,323,336110,196,767105,686,314111,853,936000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,626,067
13,037,828
11,130,476
2,787,281
1,397,242
6,987,332
3,156,486
4,471,410
622,921
7,010,390
6,421,638
1,031,097
572,140
615,726
21,541,405
16,259,129
4,553,247
4,474,539
3,485,311
5,232,989
6,812,687
4,397,217
6,776,029
5,525,676
4,857,575
5,409,092
5,859,934
7,535,166
7,961,794
7,961,7947,535,1665,859,9345,409,0924,857,5755,525,6766,776,0294,397,2176,812,6875,232,9893,485,3114,474,5394,553,24716,259,12921,541,405615,726572,1401,031,0976,421,6387,010,390622,9214,471,4103,156,4866,987,3321,397,2422,787,28111,130,47613,037,82817,626,067000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,609,417
5,959,896
5,560,375
6,500,860
7,131,369
8,366,990
5,132,617
6,138,294
6,448,952
13,968,499
10,978,210
11,714,488
8,193,609
9,002,193
9,680,126
8,290,334
8,534,797
9,098,899
8,837,967
8,107,255
3,703,950
3,884,899
4,408,883
4,484,494
5,126,674
5,500,414
4,424,648
3,934,685
3,702,653
3,702,6533,934,6854,424,6485,500,4145,126,6744,484,4944,408,8833,884,8993,703,9508,107,2558,837,9679,098,8998,534,7978,290,3349,680,1269,002,1938,193,60911,714,48810,978,21013,968,4996,448,9526,138,2945,132,6178,366,9907,131,3696,500,8605,560,3755,959,8964,609,417000000000000000
       Net Receivables 
73,691,801
74,769,164
72,813,805
73,208,071
72,193,122
71,132,079
70,732,301
70,486,967
66,030,104
66,572,925
70,968,267
66,542,178
68,102,641
68,776,537
67,748,272
69,005,121
64,450,149
69,630,066
72,234,228
72,916,114
67,688,834
68,007,393
70,461,504
74,574,273
70,041,559
64,799,838
64,043,523
63,698,229
56,328,013
50,011,424
43,887,738
35,556,178
31,179,462
30,842,235
27,400,002
30,281,245
31,510,017
28,886,706
30,286,603
29,456,305
31,433,469
36,723,613
32,191,215
33,488,719
33,488,71932,191,21536,723,61331,433,46929,456,30530,286,60328,886,70631,510,01730,281,24527,400,00230,842,23531,179,46235,556,17843,887,73850,011,42456,328,01363,698,22964,043,52364,799,83870,041,55974,574,27370,461,50468,007,39367,688,83472,916,11472,234,22869,630,06664,450,14969,005,12167,748,27268,776,53768,102,64166,542,17870,968,26766,572,92566,030,10470,486,96770,732,30171,132,07972,193,12273,208,07172,813,80574,769,16473,691,801
       Other Current Assets 
581,402
893,614
521,643
840,466
933,825
527,016
563,737
1,151,466
1,265,716
1,213,953
1,101,261
460,368
537,526
468,501
1,648,685
1,481,370
1,565,043
4,957,046
3,512,343
3,895,877
6,543,779
7,481,375
8,564,592
2,415,615
-1
0
0
829,919
1,372,978
1,608,294
3,200,395
263,020
269,645
93,905
236,414
132,322
137,360
33,979
599,539
0
0
167,892
0
0
00167,89200599,53933,979137,360132,322236,41493,905269,645263,0203,200,3951,608,2941,372,978829,91900-12,415,6158,564,5927,481,3756,543,7793,895,8773,512,3434,957,0461,565,0431,481,3701,648,685468,501537,526460,3681,101,2611,213,9531,265,7161,151,466563,737527,016933,825840,466521,643893,614581,402
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138,537,940
142,033,948
148,224,871
163,700,095
161,248,327
162,416,422
163,063,455
162,447,717
161,363,320
160,350,300
160,652,301
155,796,951
155,673,903
154,785,249
155,602,493
159,742,895
156,232,233
156,806,029
155,914,155
155,112,608
155,112,608155,914,155156,806,029156,232,233159,742,895155,602,493154,785,249155,673,903155,796,951160,652,301160,350,300161,363,320162,447,717163,063,455162,416,422161,248,327163,700,095148,224,871142,033,948138,537,940000000000000000000000000
       Property Plant Equipment 
76,896,507
78,223,734
78,341,227
77,866,941
77,430,656
77,017,924
76,866,626
78,001,058
79,003,842
78,648,424
84,485,494
98,089,064
99,841,994
100,477,458
102,891,342
105,795,769
106,984,792
106,867,033
114,422,568
125,420,436
127,790,848
127,618,981
124,412,830
131,418,129
132,870,077
135,620,699
140,770,964
154,201,779
154,353,536
155,429,200
155,219,714
149,944,389
149,172,973
148,256,626
148,137,404
142,861,096
142,502,940
141,541,288
141,877,733
141,776,577
141,578,114
141,986,383
141,343,140
140,195,918
140,195,918141,343,140141,986,383141,578,114141,776,577141,877,733141,541,288142,502,940142,861,096148,137,404148,256,626149,172,973149,944,389155,219,714155,429,200154,353,536154,201,779140,770,964135,620,699132,870,077131,418,129124,412,830127,618,981127,790,848125,420,436114,422,568106,867,033106,984,792105,795,769102,891,342100,477,45899,841,99498,089,06484,485,49478,648,42479,003,84278,001,05876,866,62677,017,92477,430,65677,866,94178,341,22778,223,73476,896,507
       Goodwill 
5,932,859
5,932,859
5,932,859
5,932,859
5,932,859
5,932,859
5,942,859
5,942,859
6,170,670
6,142,859
5,942,859
444,417
444,417
444,417
444,417
434,417
434,417
434,417
434,417
434,417
434,417
434,417
434,417
434,417
998,937
1,594,937
1,594,937
434,417
434,417
434,417
434,417
434,417
434,417
0
0
0
0
0
0
0
0
0
0
0
00000000000434,417434,417434,417434,417434,417434,4171,594,9371,594,937998,937434,417434,417434,417434,417434,417434,417434,417434,417434,417444,417444,417444,417444,4175,942,8596,142,8596,170,6705,942,8595,942,8595,932,8595,932,8595,932,8595,932,8595,932,8595,932,859
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,080,261
1,220,618
604,609
723,065
901,520
1,144,977
1,394,293
1,527,552
1,908,222
2,325,453
2,720,231
3,232,646
3,709,018
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003,709,0183,232,6462,720,2312,325,4531,908,2221,527,5521,394,2931,144,977901,520723,065604,6091,220,6181,080,261000000000000000
       Intangible Assets 
10,263,627
10,261,362
10,074,642
10,256,944
10,254,878
8,719,871
8,727,867
8,725,863
8,953,086
8,923,153
8,648,017
3,077,658
3,185,425
2,884,612
2,355,368
1,770,562
1,602,858
1,607,932
1,148,583
1,712,579
1,698,753
1,139,784
1,137,133
1,379,820
1,363,120
1,341,021
1,318,923
569,704
547,605
298,163
276,278
330,029
312,954
295,880
278,805
247,389
230,315
213,406
196,580
318,469
304,411
288,500
272,664
267,486
267,486272,664288,500304,411318,469196,580213,406230,315247,389278,805295,880312,954330,029276,278298,163547,605569,7041,318,9231,341,0211,363,1201,379,8201,137,1331,139,7841,698,7531,712,5791,148,5831,607,9321,602,8581,770,5622,355,3682,884,6123,185,4253,077,6588,648,0178,923,1538,953,0868,725,8638,727,8678,719,87110,254,87810,256,94410,074,64210,261,36210,263,627
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
463,107
0
0
631,000
665,312
0
551,946
467,355
-1
419,741
0
416,279
403,563
374,780
0
313,200
0
0
348,275
335,330
335,330348,27500313,2000374,780403,563416,2790419,741-1467,355551,9460665,312631,00000463,107000000000000000000000000
> Total Liabilities 
119,945,742
122,221,942
118,943,353
119,212,931
119,266,072
117,180,776
112,559,699
117,508,143
122,414,514
121,620,771
119,952,611
132,297,801
134,632,867
130,523,261
121,975,001
126,395,479
122,589,970
121,259,435
121,528,866
133,358,052
145,048,448
141,255,745
148,517,310
150,001,919
163,735,876
168,430,628
171,718,583
184,246,225
183,476,265
175,993,458
164,652,676
152,250,254
148,969,441
140,438,339
137,499,347
136,802,455
136,589,999
133,016,451
134,532,650
135,182,359
136,582,406
140,323,892
143,132,153
147,794,261
147,794,261143,132,153140,323,892136,582,406135,182,359134,532,650133,016,451136,589,999136,802,455137,499,347140,438,339148,969,441152,250,254164,652,676175,993,458183,476,265184,246,225171,718,583168,430,628163,735,876150,001,919148,517,310141,255,745145,048,448133,358,052121,528,866121,259,435122,589,970126,395,479121,975,001130,523,261134,632,867132,297,801119,952,611121,620,771122,414,514117,508,143112,559,699117,180,776119,266,072119,212,931118,943,353122,221,942119,945,742
   > Total Current Liabilities 
92,760,345
95,030,071
91,613,764
111,478,475
111,554,496
106,484,091
101,954,785
107,157,735
111,891,489
111,297,358
110,139,403
117,106,432
119,852,995
115,738,133
106,739,247
110,506,328
106,227,190
105,094,951
105,172,753
114,536,162
125,594,318
120,323,979
123,201,338
123,355,335
125,297,393
125,901,796
127,334,890
133,382,418
144,828,039
137,439,726
130,522,525
125,320,034
122,336,709
115,003,868
112,249,521
113,087,639
112,002,962
108,491,612
107,411,508
110,821,454
112,514,971
118,620,798
114,000,685
116,372,828
116,372,828114,000,685118,620,798112,514,971110,821,454107,411,508108,491,612112,002,962113,087,639112,249,521115,003,868122,336,709125,320,034130,522,525137,439,726144,828,039133,382,418127,334,890125,901,796125,297,393123,355,335123,201,338120,323,979125,594,318114,536,162105,172,753105,094,951106,227,190110,506,328106,739,247115,738,133119,852,995117,106,432110,139,403111,297,358111,891,489107,157,735101,954,785106,484,091111,554,496111,478,47591,613,76495,030,07192,760,345
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83,684,318
78,629,485
76,329,317
93,100
93,100
93,100
1,056,800
1,256,700
1,238,080
94,408,570
92,053,081
91,688,193
92,399,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000092,399,09991,688,19392,053,08194,408,5701,238,0801,256,7001,056,80093,10093,10093,10076,329,31778,629,48583,684,318000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83,684,318
78,629,485
76,329,317
93,100
93,100
93,100
1,056,800
1,256,700
1,238,080
94,408,570
92,053,081
91,688,193
92,399,099
103,278,335
95,891,175
90,490,213
90,020,507
90,148,129
85,675,221
84,425,119
76,925,269
76,394,730
75,129,739
74,092,242
74,808,764
74,928,696
79,912,939
74,403,729
76,514,811
76,514,81174,403,72979,912,93974,928,69674,808,76474,092,24275,129,73976,394,73076,925,26984,425,11985,675,22190,148,12990,020,50790,490,21395,891,175103,278,33592,399,09991,688,19392,053,08194,408,5701,238,0801,256,7001,056,80093,10093,10093,10076,329,31778,629,48583,684,318000000000000000
       Accounts payable 
11,864,117
11,579,238
10,074,385
8,950,701
8,743,779
9,904,474
10,449,970
11,056,856
10,441,221
10,723,626
10,372,052
10,351,444
11,496,591
13,667,814
11,407,263
13,364,883
12,485,058
11,828,264
13,995,375
14,943,619
15,194,519
15,002,113
15,224,271
15,481,287
16,472,959
18,477,057
18,606,880
16,683,341
16,548,296
15,494,756
15,707,883
15,905,215
16,807,649
14,578,741
12,930,255
13,632,536
14,929,315
14,185,258
13,322,610
15,676,949
17,721,786
17,485,328
19,040,530
16,746,436
16,746,43619,040,53017,485,32817,721,78615,676,94913,322,61014,185,25814,929,31513,632,53612,930,25514,578,74116,807,64915,905,21515,707,88315,494,75616,548,29616,683,34118,606,88018,477,05716,472,95915,481,28715,224,27115,002,11315,194,51914,943,61913,995,37511,828,26412,485,05813,364,88311,407,26313,667,81411,496,59110,351,44410,372,05210,723,62610,441,22111,056,85610,449,9709,904,4748,743,7798,950,70110,074,38511,579,23811,864,117
       Other Current Liabilities 
10,346,077
8,803,115
11,565,192
11,434,883
11,611,141
10,129,809
10,599,998
10,651,470
11,489,530
11,332,374
11,941,803
15,798,786
15,955,277
15,741,028
13,139,694
13,643,327
15,261,608
17,067,711
11,579,326
15,480,695
18,665,362
8,868,239
9,432,384
10,474,298
8,822,777
3,478,935
8,243,809
15,550,674
17,275,560
16,243,943
14,020,136
8,665,371
8,411,008
8,776,337
9,131,344
9,156,254
8,638,661
7,139,163
7,267,525
2,726,919
2,078,644
5,398,813
1,482,413
1,572,372
1,572,3721,482,4135,398,8132,078,6442,726,9197,267,5257,139,1638,638,6619,156,2549,131,3448,776,3378,411,0088,665,37114,020,13616,243,94317,275,56015,550,6748,243,8093,478,9358,822,77710,474,2989,432,3848,868,23918,665,36215,480,69511,579,32617,067,71115,261,60813,643,32713,139,69415,741,02815,955,27715,798,78611,941,80311,332,37411,489,53010,651,47010,599,99810,129,80911,611,14111,434,88311,565,1928,803,11510,346,077
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,438,483
42,528,832
44,383,693
50,863,807
38,648,226
38,553,732
34,130,151
26,930,220
26,632,732
25,434,471
25,249,826
24,301,734
24,587,037
24,524,839
27,121,142
24,360,905
24,067,435
21,703,093
29,131,468
31,421,433
31,421,43329,131,46821,703,09324,067,43524,360,90527,121,14224,524,83924,587,03724,301,73425,249,82625,434,47126,632,73226,930,22034,130,15138,553,73238,648,22650,863,80744,383,69342,528,83238,438,483000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-83,684,318
-78,629,485
-76,329,317
-93,100
-93,100
-93,100
-1,056,800
-1,256,700
-1,238,080
-94,305,478
-91,909,119
-90,759,396
-90,753,697
2,091,579
2,353,073
2,589,207
2,385,055
2,154,750
1,969,171
2,452,126
2,247,912
2,277,345
2,094,837
2,539,711
2,256,718
1,921,840
1,652,491
1,563,151
1,383,187
1,383,1871,563,1511,652,4911,921,8402,256,7182,539,7112,094,8372,277,3452,247,9122,452,1261,969,1712,154,7502,385,0552,589,2072,353,0732,091,579-90,753,697-90,759,396-91,909,119-94,305,478-1,238,080-1,256,700-1,056,800-93,100-93,100-93,100-76,329,317-78,629,485-83,684,318000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
159,732
143,223
131,714
0
0
117,412
106,128
0
83,560
72,276
60,992
0
38,424
27,140
15,856
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000015,85627,14038,424060,99272,27683,5600106,128117,41200131,714143,223159,7320000000000000000
> Total Stockholder Equity
67,938,415
68,999,557
68,629,913
68,488,679
68,238,658
68,764,717
68,644,532
68,981,572
67,868,584
66,044,351
73,311,593
63,196,529
64,818,030
67,578,421
90,644,579
90,994,622
90,149,596
96,236,482
96,560,097
97,708,318
92,815,791
92,549,305
90,338,863
89,679,804
91,847,454
85,609,137
84,314,354
76,509,603
71,502,673
95,933,584
96,396,687
87,201,273
87,811,050
88,600,277
88,457,116
80,256,950
81,216,939
83,386,570
83,474,228
89,522,123
90,102,695
89,892,308
88,360,069
83,453,011
83,453,01188,360,06989,892,30890,102,69589,522,12383,474,22883,386,57081,216,93980,256,95088,457,11688,600,27787,811,05087,201,27396,396,68795,933,58471,502,67376,509,60384,314,35485,609,13791,847,45489,679,80490,338,86392,549,30592,815,79197,708,31896,560,09796,236,48290,149,59690,994,62290,644,57967,578,42164,818,03063,196,52973,311,59366,044,35167,868,58468,981,57268,644,53268,764,71768,238,65868,488,67968,629,91368,999,55767,938,415
   Common Stock
8,500,000
8,500,000
8,500,000
8,500,000
8,755,000
8,755,000
8,755,000
8,755,000
8,755,000
9,055,000
9,055,000
9,055,000
9,055,000
9,365,000
11,610,000
11,610,000
11,610,000
12,020,000
12,020,000
12,020,000
12,270,000
12,270,000
12,270,000
12,270,000
12,270,000
12,270,000
12,270,000
12,270,000
12,312,891
16,500,540
16,976,727
16,976,727
16,976,727
16,976,727
16,976,727
16,976,727
16,976,727
16,976,727
16,976,727
0
0
16,976,727
0
0
0016,976,7270016,976,72716,976,72716,976,72716,976,72716,976,72716,976,72716,976,72716,976,72716,976,72716,500,54012,312,89112,270,00012,270,00012,270,00012,270,00012,270,00012,270,00012,270,00012,270,00012,020,00012,020,00012,020,00011,610,00011,610,00011,610,0009,365,0009,055,0009,055,0009,055,0009,055,0008,755,0008,755,0008,755,0008,755,0008,755,0008,500,0008,500,0008,500,0008,500,000
   Retained Earnings 
12,322,203
12,322,203
12,322,203
12,322,203
12,322,203
12,322,203
12,322,203
12,322,203
12,322,203
12,322,203
18,433,272
0
0
0
0
13,656,171
12,811,145
18,527,097
18,852,619
20,000,937
15,164,458
17,497,198
15,801,282
15,142,224
11,567,186
6,321,957
4,894,045
-8,270,669
-13,550,802
-23,157,428
-27,975,888
-33,723,480
-33,113,703
-31,632,361
-31,775,522
-39,975,688
3,120,007
5,289,639
5,377,296
11,425,191
12,005,763
11,866,108
10,925,585
6,031,008
6,031,00810,925,58511,866,10812,005,76311,425,1915,377,2965,289,6393,120,007-39,975,688-31,775,522-31,632,361-33,113,703-33,723,480-27,975,888-23,157,428-13,550,802-8,270,6694,894,0456,321,95711,567,18615,142,22415,801,28217,497,19815,164,45820,000,93718,852,61918,527,09712,811,14513,656,171000018,433,27212,322,20312,322,20312,322,20312,322,20312,322,20312,322,20312,322,20312,322,20312,322,20312,322,203
   Capital Surplus 00000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-540,011-540,011-540,011-499,863-499,863-499,863-462,550-462,550-462,550-462,550-447,577-447,577-447,577-447,577-440,466-440,466-440,466-440,466-435,433-435,433-435,433-435,433-435,433
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,905,797
24,905,798
24,905,798
24,905,798
24,905,798
24,905,798
22,313,574
21,800,910
21,800,909
21,800,909
21,800,909
21,800,910
29,394,214
29,394,214
29,394,214
29,394,214
27,316,677
27,316,677
26,482,694
26,482,694
26,482,694
26,482,694
26,482,694
26,482,694
0
0
26,482,694
0
0
0026,482,6940026,482,69426,482,69426,482,69426,482,69426,482,69426,482,69427,316,67727,316,67729,394,21429,394,21429,394,21429,394,21421,800,91021,800,90921,800,90921,800,90921,800,91022,313,57424,905,79824,905,79824,905,79824,905,79824,905,79824,905,797000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue169,567,373
Cost of Revenue-74,213,381
Gross Profit95,353,99295,353,992
 
Operating Income (+$)
Gross Profit95,353,992
Operating Expense-168,603,608
Operating Income963,765-73,249,616
 
Operating Expense (+$)
Research Development2,969,848
Selling General Administrative72,477,917
Selling And Marketing Expenses0
Operating Expense168,603,60875,447,765
 
Net Interest Income (+$)
Interest Income223,577
Interest Expense-5,137,471
Other Finance Cost-1
Net Interest Income-4,913,893
 
Pretax Income (+$)
Operating Income963,765
Net Interest Income-4,913,893
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,781,634963,765
EBIT - interestExpense = -5,137,471
-4,524,837
612,634
Interest Expense5,137,471
Earnings Before Interest and Taxes (EBIT)0355,837
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-4,781,634
Tax Provision-92,609
Net Income From Continuing Ops-4,874,243-4,874,243
Net Income-4,524,837
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net04,913,893
 

Technical Analysis of Myungmoon Phar
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Myungmoon Phar. The general trend of Myungmoon Phar is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Myungmoon Phar's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Myungmoon Phar.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2,330 < 2,340 < 2,340.

The bearish price targets are: 2,040 > 1,962.

Tweet this
Myungmoon Phar Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Myungmoon Phar. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Myungmoon Phar Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Myungmoon Phar. The current macd is -31.74777023.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Myungmoon Phar price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Myungmoon Phar. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Myungmoon Phar price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Myungmoon Phar Daily Moving Average Convergence/Divergence (MACD) ChartMyungmoon Phar Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Myungmoon Phar. The current adx is 21.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Myungmoon Phar shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Myungmoon Phar Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Myungmoon Phar. The current sar is 2,306.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Myungmoon Phar Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Myungmoon Phar. The current rsi is 39.50. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Myungmoon Phar Daily Relative Strength Index (RSI) ChartMyungmoon Phar Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Myungmoon Phar. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Myungmoon Phar price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Myungmoon Phar Daily Stochastic Oscillator ChartMyungmoon Phar Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Myungmoon Phar. The current cci is -107.11430855.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Myungmoon Phar Daily Commodity Channel Index (CCI) ChartMyungmoon Phar Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Myungmoon Phar. The current cmo is -29.94223825.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Myungmoon Phar Daily Chande Momentum Oscillator (CMO) ChartMyungmoon Phar Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Myungmoon Phar. The current willr is -82.45614035.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Myungmoon Phar Daily Williams %R ChartMyungmoon Phar Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Myungmoon Phar.

Myungmoon Phar Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Myungmoon Phar. The current atr is 61.73.

Myungmoon Phar Daily Average True Range (ATR) ChartMyungmoon Phar Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Myungmoon Phar. The current obv is 11,753,193.

Myungmoon Phar Daily On-Balance Volume (OBV) ChartMyungmoon Phar Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Myungmoon Phar. The current mfi is 17.05.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Myungmoon Phar Daily Money Flow Index (MFI) ChartMyungmoon Phar Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Myungmoon Phar.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Myungmoon Phar Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Myungmoon Phar based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.500
Ma 20Greater thanMa 502,176.000
Ma 50Greater thanMa 1002,157.700
Ma 100Greater thanMa 2002,217.450
OpenGreater thanClose2,075.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Myungmoon Phar with someone you think should read this too:
  • Are you bullish or bearish on Myungmoon Phar? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Myungmoon Phar? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Myungmoon Phar

I send you an email if I find something interesting about Myungmoon Phar.


Comments

How you think about this?

Leave a comment

Stay informed about Myungmoon Phar.

Receive notifications about Myungmoon Phar in your mailbox!